Clinical Trial Update: Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tovorafenib for craniopharyngioma in children and young adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniopharyngioma

Drugs mentioned

• tovorafenib (tovorafenib)

Snippet

Sponsor: Sabine Mueller, MD, PhD | Conditions: Craniopharyngioma, Child, Craniopharyngioma | Phase 2 | Status: RECRUITING